Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1006065Generated: October 26, 2026

Trifluoroacetic acid → N-(2-(3-methoxyphenyl) ethyl)-4-(2-ethyl-5-methoxy-benzyl)piperidine Hydrochloride

https://huagongshe.com/reaction/1006065

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTrifluoroacetic acidHCID 6422—
ReactantTriethylsilaneHCID 12052—
ReactantTriethylsilanolHCID 69005—
ReactantSodium BicarbonateHCID 516892—
ReactantEther hydrochlorideHCID 10953452—
ReactantN-(2-(3-methoxyphenyl)ethyl)-4-(2-(1-hydroxyethyl)-5-methoxybenzyl)piperidineHCID 22675304—
ReactantN-(2-(3-methoxyphenyl)ethyl)-4-(2-ethyl-5-methoxybenzyl)piperidineHCID 22675314—
SolventDiethyl EtherHCID 3283—
SolventDichloromethaneHCID 6344—
SolventEthyl AcetateHCID 8857—
ProductN-(2-(3-methoxyphenyl) ethyl)-4-(2-ethyl-5-methoxy-benzyl)piperidine HydrochlorideHCID 2267531379.6%

Reaction Steps

Trifluoroacetic acid (0.5 ml) was added dropwise to a solution of N-(2-(3-methoxyphenyl)ethyl)-4-(2-(1-hydroxyethyl)-5-methoxybenzyl)piperidine (250 mg, 0.65 mmol) and triethylsilane (91 mg, 0.78 mmol) in dichloromethane (5 ml) under ice-cooling, and the reaction mixture was stirred as it was for 2 hours. Ethyl acetate and a saturated aqueous sodium hydrogencarbonate solution were added thereto to effect separation, and the organic layer was washed with a saturated aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and then distilled under reduced pressure to remove the solvent. The residue was purified by a silica gel column chromatography (chloroform/methanol=50/1) to obtain a mixture of N-(2-(3-methoxyphenyl)ethyl)-4-(2-ethyl-5-methoxybenzyl)piperidine and triethylsilanol. This mixture was dissolved in dichloromethane (5 ml), followed by adding thereto a 1N hydrogen chloride-diethyl ether solution (1 ml, 1 mmol), and the solvent was distilled off under reduced pressure. The residue was suspended in diethyl ether and the precipitate was collected by filtration and washed with diethyl ether to obtain the title compound (209 mg, 79%) as white powder.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06787560B2
Source datasetuspto-grants-2004_09
ORD IDord-32603b56029e4efabf3f59675f734cf0
Source noteuspto-grants-2004_09